We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · September 26, 2019

Oral Semaglutide Is Safe and Effective Added to Insulin ± Metformin in Patients With T2D

Diabetes Care


Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes Care
Efficacy, Safety and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin ± Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial
Diabetes Care 2019 Sep 17;[EPub Ahead of Print], B Zinman, VR Aroda, JB Buse, B Cariou, SB Harris, ST Hoff, KB Pedersen, MJ Tarp-Johansen, E Araki

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading